- Home
- PMAX vs AEON Comparison
PMAX vs AEON Comparison
Compare PMAX & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMAX
- AEON
- Stock Information
- Founded
- PMAX 2019
- AEON N/A
- Country
- PMAX Hong Kong
- AEON United States
- Employees
- PMAX N/A
- AEON N/A
- Industry
- PMAX
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- PMAX
- AEON Health Care
- Exchange
- PMAX Nasdaq
- AEON Nasdaq
- Market Cap
- PMAX 6.5M
- AEON 5.7M
- IPO Year
- PMAX 2024
- AEON N/A
- Fundamental
- Price
- PMAX $0.42
- AEON $0.82
- Analyst Decision
- PMAX
- AEON Strong Buy
- Analyst Count
- PMAX 0
- AEON 1
- Target Price
- PMAX N/A
- AEON $360.00
- AVG Volume (30 Days)
- PMAX 21.9M
- AEON 1.9M
- Earning Date
- PMAX 04-28-2025
- AEON 05-14-2025
- Dividend Yield
- PMAX N/A
- AEON N/A
- EPS Growth
- PMAX N/A
- AEON N/A
- EPS
- PMAX N/A
- AEON 73.23
- Revenue
- PMAX $4,694,079.00
- AEON N/A
- Revenue This Year
- PMAX N/A
- AEON N/A
- Revenue Next Year
- PMAX N/A
- AEON N/A
- P/E Ratio
- PMAX N/A
- AEON $0.01
- Revenue Growth
- PMAX N/A
- AEON N/A
- 52 Week Low
- PMAX $0.28
- AEON $0.38
- 52 Week High
- PMAX $4.70
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- PMAX N/A
- AEON 67.31
- Support Level
- PMAX N/A
- AEON $0.53
- Resistance Level
- PMAX N/A
- AEON $0.85
- Average True Range (ATR)
- PMAX 0.00
- AEON 0.08
- MACD
- PMAX 0.00
- AEON 0.05
- Stochastic Oscillator
- PMAX 0.00
- AEON 92.78
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.